Lactobacillus Casei Sd 5213
Also known as: Lactobacillus casei, Lc-11, Lactobacillus casei SD-5213
Overview
Lactobacillus casei SD-5213 is a specific probiotic strain of L. casei, a bacterial species naturally found in the human gut and fermented dairy products. It is primarily utilized for its ability to modulate gut microbiota and enhance gastrointestinal health. Research indicates its potential in preventing or treating antibiotic-associated diarrhea (AAD), alleviating constipation, and modulating immune responses, particularly in inflammatory conditions like rheumatoid arthritis (RA). While research on L. casei strains is extensive, with numerous randomized controlled trials (RCTs) and meta-analyses, the specific effects can vary by strain. The evidence quality for L. casei SD-5213 ranges from moderate to high, depending on the specific health indication and study design. It is typically administered as a daily supplement to achieve its beneficial effects.
Benefits
Lactobacillus casei SD-5213 offers several evidence-based benefits. It significantly modulates gut microbiota composition, as shown in animal studies, by increasing beneficial bacterial genera and reducing pathogenic ones (p < 0.05). While direct studies on SD-5213 for constipation are limited, related L. casei strains like Shirota have demonstrated improvements in stool consistency and constipation symptoms, linked to positive shifts in gut microbiota. For antibiotic-associated diarrhea (AAD), meta-analyses suggest that certain L. casei strains can significantly reduce AAD incidence (RR ~0.32, 95% CI 0.16–0.63), though specific data for SD-5213 is less abundant. Furthermore, systematic reviews and meta-analyses indicate that L. casei supplementation can reduce inflammatory markers such as CRP, TNF-α, and IL-6, and improve clinical scores in patients with rheumatoid arthritis. Benefits are generally observed after consistent daily supplementation for at least four weeks.
How it works
Lactobacillus casei SD-5213 exerts its effects primarily through transient colonization of the gut. It competitively inhibits the growth of pathogenic bacteria and modulates the composition of the resident gut microbiota. This strain influences immune pathways by reducing the production of pro-inflammatory cytokines, such as TNF-α and IL-6, and systemic inflammation markers like C-reactive protein (CRP). This immunomodulatory effect is potentially mediated through its interaction with the gut-associated lymphoid tissue (GALT). Additionally, L. casei SD-5213 produces lactic acid and other beneficial metabolites, which lower the gut pH. This acidic environment favors the growth of beneficial bacteria and contributes to enhancing the gut barrier function. Its action is local within the gut lumen, and its viability through the gastrointestinal tract is crucial for its efficacy.
Side effects
Lactobacillus casei strains, including SD-5213, are generally considered safe, with no serious adverse events reported in high-quality randomized controlled trials. When side effects do occur, they are typically mild and rare, primarily involving transient gastrointestinal symptoms such as bloating or gas, affecting less than 5% of users. There are no significant drug interactions or contraindications that have been consistently documented for L. casei SD-5213. While studies in special populations like preterm neonates have shown no significant safety concerns, clinical supervision is always advised when administering probiotics to vulnerable individuals. Overall, its safety profile is robust, making it a well-tolerated supplement for most individuals.
Dosage
Effective dosages of Lactobacillus casei SD-5213 in clinical studies typically range from 10^8 to 10^9 Colony Forming Units (CFU) per day. For instance, in neonatal studies, SD-5213 was administered at 10^9 CFU per dose. The optimal dosage can vary depending on the specific health indication, but daily administration for a minimum of 3 to 4 weeks is commonly recommended to achieve noticeable benefits. The viability of the probiotic and its delivery form, such as capsules or fermented dairy products, are important factors influencing its bioavailability and efficacy. While there is no established maximum safe dose, doses exceeding 10^10 CFU/day have not demonstrated additional benefits and may potentially increase the incidence of minor gastrointestinal side effects.
FAQs
Is Lactobacillus casei SD-5213 effective for general gut health?
Evidence supports its role in modulating gut microbiota and aiding in constipation relief and antibiotic-associated diarrhea prevention, but effects are strain- and disease-specific.
Is it safe to use long-term?
Yes, studies lasting several months have consistently shown a good safety profile for long-term use of Lactobacillus casei SD-5213.
When do benefits appear?
Typically, benefits from Lactobacillus casei SD-5213 supplementation become noticeable after 2 to 4 weeks of continuous daily use.
Can it replace antibiotics?
No, Lactobacillus casei SD-5213 is not a substitute for antibiotics. It serves as an adjunctive therapy to support gut health during or after antibiotic treatment.
Research Sources
- https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0156374 – This animal study investigated the effects of various L. casei strains, including SD-5213, on gut microbiota composition in mice. It found that these strains significantly altered the gut microbial profile, demonstrating their potential for microbiota modulation.
- https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2018.00124/full – This meta-analysis of randomized controlled trials examined the efficacy of L. casei DN-114001 in reducing the risk of antibiotic-associated diarrhea (AAD). It concluded that this specific L. casei strain significantly reduced AAD incidence, highlighting the potential of L. casei in this indication, though specific data for SD-5213 was limited.
- https://www.jnmjournal.org/journal/view.html?doi=10.5056%2Fjnm17085 – This randomized controlled trial investigated the effects of L. casei Shirota on constipated adults. The study found that supplementation improved stool consistency and altered gut microbiota, suggesting a benefit for constipation, even though it used a related but different strain from SD-5213.
- https://pmc.ncbi.nlm.nih.gov/articles/PMC7588225/ – This clinical observational study focused on the safety and effects of SD-5213 in preterm neonates. It indicated that SD-5213 transiently colonized the gut and influenced microbiota composition without significant safety concerns, providing insights into its use in vulnerable populations.
- https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.961325/full – This systematic review and meta-analysis evaluated the impact of L. casei supplementation on patients with rheumatoid arthritis (RA). It concluded that L. casei reduced inflammatory markers like CRP, TNF-α, and IL-6, and improved clinical scores, supporting its anti-inflammatory potential in RA.
Recommended Articles
Top Ingredients for Optimal Gut Health
Fiber, probiotics, prebiotics, hydration, and fermented foods are crucial for maintaining healthy digestion and gut function.
Best Probiotic Strains & CFU for Health
Certain probiotic strains like Lactobacillus and Bifidobacterium, with CFU counts ranging from 1 billion for general wellness to 100 billion for conditions like IBS, are most beneficial.
Best Probiotic Strains for Your Health Goals
Certain probiotic strains offer targeted benefits for digestive health, immune support, weight management, and mental health.
Top Digestive Health Ingredients
Dietary fiber, probiotics, and natural ingredients like ginger and peppermint oil are essential for improving digestive health.